Review Article
  

Prevalence of Asthma, COPD, and Chronic Bronchitis in Iran: A Systematic Review and Meta-analysis

Abstract

In this study, we aimed to conduct a meta-analysis on the results of eligible studies to estimate the prevalence of asthma, COPD, and Chronic bronchitis in Iran. International and Iranian databases including PubMed, Scopus, Web of Science, Iranmedex, and scientific information database (SID) were searched for population–based studies that had reported the prevalence of asthma and COPD from 1990 to 2015. We conducted the meta-analysis using metaprop application of Stata statistical software. I-Squared was used for calculating heterogeneity among the studies. To determine causes of heterogeneity, subgroup analysis and meta-regression method were used. Based on the results of random effect method, the overall prevalence of asthma ever was 4.56% (3.76%-5.36%) among men while it was 4.17% (3.42%-4.91%) among women. Pooled prevalence of current asthma was 7.95% while confidence interval changed from 5.85% to 10.06% (men 5.83% (2.75%-8.92%), women 9.13% (3.35%-14.94%)). Also based on the results of random effect model pooled prevalence of chronic bronchitis of five studies was 5.57%. It seems that the total crude prevalence of current asthma in Iran is less than many other countries such as Kuwait, Lebanon, Thailand, Japan, Australia and Germany and is higher than some other countries such as Oman, Pakistan, South Korea, India, China, Taiwan, Indonesia, Spain, Russia, and Greece. On the other hand, Iran is in middle situation in terms of the prevalence current asthma. Our results can fill the information and knowledge gaps about the status of the prevalence of respiratory diseases in Iran.

1. Cruz AA, Bousquet J, Khaltaev N. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. World Health Organization;2007.

2. Milenkovic B, Mitic-Milikic M, Rebic P, Vukcevic M, Dudvarski-Ilic A, Nagorni-Obradovic L, et al. Asthma and Chronic Bronchitis Symptoms among Adult Population of Belgrade. Srpski Arhiv Za Celokupno Lekarstvo 2011; 139(3-4):149-54.

3. Masoli M, Fabian D, Holt S, Beasley R, Global Initiative for Asthma P. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59(5):469-78.

4. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27(2):397-412.

5. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27(1):188-207.

6. Manning PJ, Goodman P, O'Sullivan A, Clancy L. Rising prevalence of asthma but declining wheeze in teenagers (1995-2003): ISAAC protocol. Ir Med J 2007;100(10):614-5.

7. Niu SR, Yang GH, Chen ZM, Wang JL, Wang GH, He XZ, et al. Emerging tobacco hazards in China: 2. Early mortality results from a prospective study BMJ 1998;317(7170):1423-4.

8. Gessner BD, Neeno T. Trends in asthma prevalence,hospitalization risk, and inhaled corticosteroid use among Alaska Native and nonnative Medicaid recipients younger than 20 years. Ann Allerg Asthma Im 2005; 94(3):372-9.

9. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet (London, England) 1997; 349(9061):1269-76.

10. Current Asthma Prevalence Percent by Age,Sex, and Race/Ethincity,United States, 2013. Center for Disease Control and Prevention. Available from: http://www.cdc.gov/asthma/asthmadata.htm

11. Demoly P, Paggiaro P, Plaza V, Bolge S, Kannan H, Sohier B, et al. Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK. Eur Respir Rev 2009; 18(112):105-12.

12. Musafiri S, van Meerbeeck J, Musango L, Brusselle G, Joos G, Seminega B, et al. Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country. Respir Med 2011; 105(11):1596-605.

13. Siafakas NM. Definition and differential diagnosis of chronic obstructive pulmonary disease. European Respiratory Monograph 2006; 38:1.

14. Entezari A, Mehrabi Y, Varesvazirian M, Pourpak Z, Moin M. A systematic review of recent asthma symptom surveys in Iranian children. Chron Respir Dis 2009;6(2):109-14.

15. Mohammadbeigi A, Hassanzadeh J, Mousavizadeh A.Prevalence of asthma in elementary school age children in Iran--a systematic review and meta analysis study. Pak J Biol Sci 2011; 14(19):887-93.

16. Ghaffari J, Aarabi M. The prevalence of pediatric asthma in the Islamic Republic of Iran: A systematic review and meta-analysis. J Pediatr Rev 2013; 1(1):2-11.

17. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. AJRCCM 1995; 152(5):77-121.

18. Toelle BG, Peat JK, Salome CM, Mellis CM, Woolcock AJ. Toward a definition of asthma for epidemiology. Am Rev Respir Dis 1992; 146(3):633-7.

19. Golshan M, Meer- Alai A, Mohammadzadeh Z, Kyani Y, Loghmanian L. Prevalence of Asthma and Related Symptoms in School-Aged Children in Zarinshahr, IRAN. Tanaffos 2002; 1(2):41-6.

20. Varmaghani M, Rashidian A, Kebriaeezadeh A, Moradi- Lakeh M, Moin M, Ghasemian A, et al. National and sub- national prevalence, trend, and burden of asthma in Iran from 1990 to 2013; the study protocol. Arch Iran Med 2014; 17(12):804-9.

21. Farzadfar F, Delavari A, Malekzadeh R, Mesdaghinia A, Jamshidi HR, Sayyari A, et al. NASBOD 2013: design,definitions, and metrics. Arch Iran Med 2014; 17(1):7-15.

22. Hamza TH, van Houwelingen HC, Stijnen T. The binomial distribution of meta-analysis was preferred to model within-study variability. J Clin Epidemiol 2008;61(1):41-51.

23. Bazazi H, Gharagozlou M, Kasaei M, ParsaeiKia A, Zahmatkesh H, Alikhani L, et al. Wheezing and asthma prevalence and associated factors among schoolchildren in Gorgan. Pajoohandeh Journal 2006; 11(52):259-63.

24. Sahebi L, Sadeghi Shabestari M. Th e prevalence of asthma, allergic rhinitis, and eczema among middle school students in Tabriz (northwestern Iran). Turk J Med Sci 2011; 41(5):927-38.

25. Khazaei HA, Hashemi SR, Aghamohammadi A, Farhoudi F, Rezaei N. The Study of Type1 Allergy Prevalence among people of South-East of Iran by Skin P rick Test Using Common Allergens. Iran J Allergy Asthma Immunol 2003; 2(3):165-8.

26. Kajbaf TZ, Asar S, Alipoor MR. Relationship between obesity and asthma symptoms among children in Ahvaz, Iran: a cross sectional study. Ital J Pediatr 2011; 37(1).

27. Zobeiri M. Prevalence, Risk Factors and Severity of Asthma Symptoms in Children of Kermanshah, IRAN: ISAAC Phase I, II. Acta Med Iran 2011; 49(3):184-8.

28. Marefati H, Nikbine H, Boskabady MH. Prevalence of exercise induced asthma in female school students. Iran J Allergy Asthma Immunol 2011; 10(4):273-9.

29. Rahimian M. The prevalence of curren asthma at high school students in Yazd in 1996-1997. The Journal of Shahid Sadoughi University of Medical Science 1998;6(4):19-22.

30. Tootoonchi P. Prevalence of asthma, related symptoms and risk factors in children younger than 5 years. Acta Medica Iranica 2004; 42(6):450-4.

31. Karami M, Mirzaei M, Ahmadiah MH.Prevalence of Asthma, Allergic rhinitis and Eczema symptoms among 13-14 year-old school children in Yazd in 2003. Scientific Medical Journal of Ahvaz university of Medical Sciences 2007; 6(3):275-9.

32. Mohammadzadeh I, Ghafari J, Savadkoohi RB, Tamaddoni A, Esmaeili Dooki MR, Navaei RA. The Prevalence of Asthma, Allergic Rhinitis and Eczema in North of Iran. Iran J Pediatr 2008; 18(2):117-22.

33. Ghaffari J, Mohammadzadeh I, Khalilian AR, Rafatpanah H, Mohammadjafari H, Davoudi A. Prevalence of asthma, allergic rhinitis and eczema in elementary schools in Sari (Iran). Caspian J Intern Med 2012;3(1):372-6.

34. Abbasi Ranjbar Z. Prevalence of Asthma Symptoms in Children. Journal of Guilan University of Medical Sciences 2005; 4(56):1-9.

35. Hassanzadeh J, Basiri F, Mohammad-Beigi A. Prevalence of asthma symptoms and allergic diseases with ISSAC method in children, Shiraz 2009. Zahedan Journal of Research in Medical Sciences 2012; 13(8):35-9.

36. Boskabady MH, Kolahdoz GH.Prevalence of asthma symptoms among the adult population in the city of Mashhad (north-east of Iran). Respirology 2002; 7:267–72.

37. HabibiKhorasani A, Janghorbani M, Gozashti H, Samareh-Fekri M. Prevalence of Asthma in elementary school children in Kerman in 1999. Journal of Kerman University of Medical Sciences 2002; 9(4):184-93.

38. Golshan M, Khanlarpoor A, Mohamad-Zadeh Z, Zahedi- Nejad N, Iran-poor R. The prevalence of asthma in adolescents in high schools in 1998-1999. Journal of Research in Medical Sciences 2000; 5(2):176-9.

39. Hedayatmofidi S, Ahmadi A, Badeleh M, Bakhsha F, Joshaghani H. Prevalence of Asthma among Schoolchildren in Gorgan, Iran by Questionnaire Surveys in 2006. J Med Sci 2007; 7(6):1054-6.

40. Shakurnia A AS, Afra M, Latifi M. Prevalence of asthma among schoolchildren in Ahvaz, Islamic Republic of Iran. East Mediterr Health J 2010; 16(6):651-6.

41. Zohal M, Hasheminasab R. prevalence of asthma among school age children in Qazvin(2003). journal of Qazvin University of Medical Sciences 2006; 9(4):63-68.

42. Mehrabi S, Delavari A, Moradi G, Ghaderi E. Prevalence of Asthma among 15 to 64 years old in Kurdistan, Iran 2006. Iranian J Epidemiology 2009; 4(3):93-98.

43. Varasteh AR, Fereidouni M, Shakeri MT, Vahedi F, Abolhasani A, Saberi Afsharian M, et el. Prevalence of allergic disorders among the population in the city of Mashhad, Northeast Iran. J Public Health 2009; 17:107–112.

44. Najafizadeh K, Fadaizadeh L, Salek S. Prevalence and severity of asthmatic symptoms in rasht students: A report from ISAAC study. Tanaffos 2008; 7(1):40-6.

45. Mirzai M, Karimi M, Mobin E, Rahim Z. The prevalence and severity of asthma, allergic rhinitis and eczema symptoms in children 6-7 years old in Yazd. J of Yazd health faculty 2007; 6(1):44-52.

46. Masjedi, Fadaizadeh L, Najafizadeh K, Dokouhaki P.Prevalence and Severity of Asthma Symptoms in Children of Tehran- International Study of Asthma and Allergies in Childhood (ISAAC). Iran J Allergy Asthma Immunol 2004; 3(1):25-30.

47. Farrokhi Sh, Gheybi MK, Movahhed A, Dehdari R,Gooya M, Keshvari S, et al. Prevalence and Risk Factors of Asthma and Allergic Diseases in Primary Schoolchildren Living in Bushehr, Iran: Phase I, III ISAAC Protocol Iran. J Allergy Asthma Immunol 2014;13(5):348-55.

48. Gharagosloo M, Khalili S, HallajMofrad M,Karimi B, Honarmand M, Jafari H, et al. Asthma, allergic rhinitis and atopic eczema in SchoolchildrenKashan (1998-1999). Tehran University Medical Journal (TUMJ) 2002;60(5):416-22.

49. Mortazavi Moghaddam Gh, Saadatjoo AR. Asthma in Iranian School children: Comparison of ISAAC Video and Written Questionnaires. Irannian Journal of Medical Sceinces 2005; 30(3):110-4.

50. Rahimi-Rad M, Hejazi ME, Behrozian R. Asthma and other allergic diseases in 13-14 year old schoolchidren in urmia: An ISAAC study. EMHJ 2007;13(5):1005-16.

51. Hatami G, Amir Azodi E, Najafi A, Razavi SH, Afrasiabi K, Afarid M, et al. Prevalence of Asthma and Asthma- related symptoms among 13-14 yr. schoolchildren in Bushehr, ISSAC. Iranian South Med J 2003; 2003:2.

52. Golshan, M., Esteki B, Dadvand P. Prevalence of self- reported respiratory symptoms in rural areas of Iran in 2000. Respirology 2002; 7(2):129-32.

53. Golshan M, Mohammadzadeh Z, Moghaddasi M, Chegeni M. Prevalence of asthma and related symptoms in school-aged children in Boroojerd, Iran. Tanaffos 1999; 1(2):22-7.

54. Golshan M., Mohammadzadeh Z, Zahedi-Nejad N, Rostam-Poor B. Prevalence of asthma and related symptoms in primary school children of Isfahan, Iran, in 1998. Asian Pac J Allergy Immunol 2001; 19(3):163-70.

55. Tazesh B, Shaabani A, Fazlollahi MR, Entezari A, Dashti R, Pourpak Z, et al. Prevalence of asthma symptoms and smoking behavior among 20-44 years old adults in Tehran: A telephone survey. Health 2013;5(3):469-74.

56. Masjedi MR, ISAAC Phase Three Data, Zanjan, Iran. http://isaac.auckland.ac.nz/phases/phasethree/phasethree. html.

57. Masjedi MR, ISAAC Phase Three Data, Birjand, Iran.. http://isaac.auckland.ac.nz/phases/phasethree/studygroup WM.html.

58. Masjedi MR, ISAAC Phase One Data, Rasht, Iran. http://isaac.auckland.ac.nz/phases/phasethree/studygroup WM.html.

59. Rajaeifard A, Moosavi Zadeh A, Pourmahmoudi A , Naeimi E, Hadinia A, Karimi A. Evaluation of Prevalence and Related Factors of Pediatric Asthma in Children Under Six Years Old With Logistic Regression and Probit. Armaghane Danesh 2011; 16(3):272-81.

60. Golshan M, Barahimi H, Nasirian K. Prevalence of chronic bronchitis and chronic respiratory symptoms in adults over the age of 35 years in Isfahan, Iran in 1998. Respirology 2001; 6(3):231-5.

61. Golshan M, Amra B, Welte T. Sample survey of chronic obstructive pulmonary disease and associated risk factors in Isfahan, Iran. Tanaffos 2011; 10(3):32-6.

62. Sharifi H, Masjedi MR, Emami H, Ghanei M, Eslaminejad A, Radmand G, et al. Interim Report from Burden of Obstructive Lung Disease (BOLD Study) in Tehran: Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease. Tanaffos 2014; 13(3):6-13.

63. Amra B, Hashemi M. Prevalence of chronic Bronchitis in Shahrekord, 1998. J Shahrekord Univ Med Sci 1999;1(2):26-30.

64. Cookson WO, Moffatt MF. Genetics of asthma and allergic disease. Human molecular genetics 2000;9(16):2359-64.

65. Agha Molaei T, Zare Sh. Distribution of smokers by stages of change of smoking: a population based study from BndarAbbass, Iran. Payesh 2009; 8(3):263-9.

66. Amiri M, Emami S R, Nabipour I, nosraty A, Iranpour D, Soltanian A, et al. Risk factors of cardiovascular diseases in Bushehr Port on the basis of The WHO MONICA Project The Persian Gulf Healthy Heart Project. ISMJ 2004; 6(2):151-61.

67. Jindal SK, Gupta D. The relationship between tobacco smoke & bronchial asthma. IJMR 2004; 120(5):443-53.

68. Martínez AN. [Pathogenesis, trigger and risk factors in asthma]. Revista alergia Mexico 2008; 56:10-23.

69. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. The European respiratory journa 2004; 23(6):932-46.

70. Molfino N A. Genetics of COPD. Chest Journal 2004;125(5):1929-40.

71. COPD prevalence in 12 Asia-Pacific countries and regions: projections based on the COPD prevalence estimation model. Respirology 2003; 8(2):192-8.

72. Miravitlles M, B Soriano J, García-Río F, Muñoz L, Duran-Tauleria E, Sanchez G, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64(10):863-8.

73. Menezes AM, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet (London, England) 2005; 366(9500):1875-81.

74. Spon RA, Bilques S, Hussain I, Khan SS, Ul-Haq I, Dolma Y. Prevalence of Chronic Bronchitis in Selected Districts of Kashmir Valley. Journal of Advanced Research in Medicine 2014; 1(1):27-32.

75. Hassanzadeh J, Mohammadbeigi A, Mousavizadeh A, Akbari M. Asthma prevalence in Iranian guidance school children, a descriptive meta-analysis. J Res Med Sci 2012; 17(3):293-7.

76. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351(9111):1225-32.

Files
IssueVol 15, No 2 (2016) QRcode
SectionReview Article(s)
Keywords
Asthma Chronic bronchitis Iran Meta-analysis Prevalence Systematic review
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Varmaghani M, Farzadfar F, Sharifi F, Rashidian A, Moin M, Moradi-Lakeh M, Rahimzadeh S, saeedi Moghaddam S, Kebriaeezadeh A. Prevalence of Asthma, COPD, and Chronic Bronchitis in Iran: A Systematic Review and Meta-analysis. Iran J Allergy Asthma Immunol. 2016;15(2):93-104.